We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,055 hedge funds and large institutions have $51.5B invested in Thermo Fisher Scientific in 2016 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 384 increasing their positions, 421 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 38

34% more call options, than puts

Call options by funds: $233M | Put options by funds: $174M

5% more capital invested

Capital invested by funds: $48.9B → $51.5B (+$2.6B)

3% more funds holding

Funds holding: 1,0241,055 (+31)

1% more funds holding in top 10

Funds holding in top 10: 7778 (+1)

9% less repeat investments, than reductions

Existing positions increased: 384 | Existing positions reduced: 421

2.57% less ownership

Funds ownership: 91.36%88.79% (-2.6%)

Holders
1,055
Holders Change
+31
Holders Change %
+3.03%
% of All Funds
28.15%
Holding in Top 10
78
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+1.3%
% of All Funds
2.08%
New
79
Increased
384
Reduced
421
Closed
38
Calls
$233M
Puts
$174M
Net Calls
+$59M
Net Calls Change
+$99.8M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
401
Cannell & Co
New York
$6.13M +$11.1K +75 +0.2%
MKC
402
M. Kraus & Co
Vermont
$6M +$27.6K +187 +0.5%
SCCM
403
Schafer Cullen Capital Management
New York
$6M -$123K -835 -2%
KFC
404
Klingenstein Fields & Co
New York
$5.99M -$132K -895 -2%
CT
405
Coastline Trust
Rhode Island
$5.97M -$53.1K -360 -0.9%
HHMI
406
Howard Hughes Medical Institute
Maryland
$5.91M -$738K -5,000 -11%
CIP
407
Chartwell Investment Partners
Pennsylvania
$5.91M
HighTower Advisors
408
HighTower Advisors
Illinois
$5.79M -$2.21M -14,997 -28%
MAM
409
Mastrapasqua Asset Management
Tennessee
$5.78M +$106K +715 +2%
HCMT
410
Highland Capital Management (Tennessee)
Tennessee
$5.73M -$602K -4,082 -10%
SAM
411
Securian Asset Management
Minnesota
$5.71M +$9.59K +65 +0.2%
TAF
412
Tredje AP-fonden
Sweden
$5.69M -$632K -4,285 -10%
FIM
413
FourPoints Investment Managers
France
$5.66M -$1.16M -7,855 -17%
PCM
414
Parsons Capital Management
Rhode Island
$5.66M -$9.59K -65 -0.2%
EAM
415
EULAV Asset Management
Florida
$5.66M
FHA
416
First Horizon Advisors
Tennessee
$5.59M -$811K -5,497 -13%
WAM
417
World Asset Management
Michigan
$5.56M +$24.9K +169 +0.5%
LPL Financial
418
LPL Financial
California
$5.52M -$4.02M -27,264 -42%
SAM
419
Silvercrest Asset Management
New York
$5.51M +$123K +832 +2%
Flossbach Von Storch
420
Flossbach Von Storch
Germany
$5.48M -$3.09M -20,960 -36%
SCA
421
Stonebridge Capital Advisors
Minnesota
$5.44M -$714K -4,837 -12%
PPSG
422
Princeton Portfolio Strategies Group
New Jersey
$5.41M +$25.8K +175 +0.5%
DWA
423
Douglass Winthrop Advisors
New York
$5.39M -$3.44M -23,319 -39%
MIH
424
Madison Investment Holdings
Wisconsin
$5.23M
BCM
425
BTC Capital Management
Iowa
$5.22M -$290K -1,963 -5%

TMO Hedge Fund Activity: Q2 2016 in Review

1,055 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2016, worth a combined $51.5B — up 5.3% from $48.9B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new TMO positions and 38 closed out — a net gain of 41 holders — while 384 added to existing stakes and 421 trimmed.

The largest buyer was Sound Shore Management, adding an estimated $180M. The largest seller was Royal London Asset Management, cutting an estimated $2.01B.

  • 1,055 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2016, up from 1,024 in Q1 2016.
  • Funds reported $51.5B of Thermo Fisher Scientific stock for Q2 2016, up 5.3% quarter-over-quarter.
  • 79 funds opened new Thermo Fisher Scientific positions in Q2 2016 and 38 closed out, a net change of +41 holders.
  • The largest Thermo Fisher Scientific buyer in Q2 2016 was Sound Shore Management, an estimated $180M added.
  • The largest Thermo Fisher Scientific seller in Q2 2016 was Royal London Asset Management, an estimated $2.01B sold.

Based on aggregated 13F filings for Q2 2016.